Coincidentally, TCGA analysis unveiled that amplification alteration in the lipogenic enzymes participating in the fatty acid biosynthesis pathway such as ACACA, ACACB, FASN, and MCAT among serous subtypes of ovarian cancer was the most abundant genetic alteration detected (Figure 3A), suggesting that high lipogenesis supports oncogenic properties of ovarian cancer. The gene discussed is ACACB; the disease is ovarian carcinoma.